Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A

被引:4
作者
Liu, Yong [1 ]
Paige, Mike [1 ]
Olson, Thao T. [2 ]
Al-Muhtasib, Nour [2 ]
Xie, Teresa [2 ]
Hou, Shujie [1 ]
White, Michael P. [1 ]
Cordova, Antoinette [1 ]
Guo, Jessica L. [1 ]
Kellar, Kenneth J. [2 ]
Xiao, Yingxian [2 ]
Brown, Milton L. [1 ]
机构
[1] Georgetown Univ, Med Ctr, Ctr Drug Discovery, Washington, DC 20057 USA
[2] Georgetown Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20057 USA
关键词
Sazetidine A; nAChR alpha 4 beta 2; Nicotinic receptor; Click chemistry; Bioisostere; Biostere; Photoaffinity label; SUSTAINED-RELEASE BUPROPION; RANDOMIZED CONTROLLED-TRIAL; PARTIAL AGONIST; DESENSITIZING AGENT; SMOKING-CESSATION; ANALGESIC AGENT; ALPHA-4-BETA-2; POTENT; VARENICLINE; BINDING;
D O I
10.1016/j.bmcl.2014.04.036
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The enantiomers of two analogs of Sazetidine-A as well as several other novel biosteric analogues were synthesized. Their binding affinities at three major nAChRs subtypes and selectivity profiles were determined. Though many (S)-enantiomers of Sazetidine-A analogs have high binding affinities and good subtype selectivities, it is not a general rule that (S)-enantiomers are better than their (R) counterparts. Compound 11, of which the ethynyl group was replaced by its' bioisostere-the triazole via click chemistry, showed a high binding affinity to alpha 4 beta 2 subtype (K-1 = 1.3 nM) and better selectivity to the alpha 4 beta 2 subtype over alpha 3 beta 4 subtype with that of Sazetidine-A. The azide compound 15, a potential photoaffinity label, showed improved high selectivity and similar binding property profile with that of Sazetidine-A. The biaryl analog 17 exhibited a much lower affinity as compared to Sazetidine-A indicating the importance of a 'long tail' side chain for alpha 4 beta 2 nAChR binding. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2954 / 2956
页数:3
相关论文
共 31 条
  • [1] Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
    Arneric, Stephen P.
    Holladay, Mark
    Williams, Michael
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : 1092 - 1101
  • [2] Nicotinic agonists, antagonists, and modulators from natural sources
    Daly, JW
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (3-4) : 513 - 552
  • [3] One-pot synthesis of 1,4-disubstituted 1,2,3-triazoles from in situ generated azides
    Feldman, AK
    Colasson, B
    Fokin, VV
    [J]. ORGANIC LETTERS, 2004, 6 (22) : 3897 - 3899
  • [4] Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
    Gonzales, David
    Rennard, Stephen I.
    Nides, Mitchell
    Oncken, Cheryl
    Azoulay, Salomon
    Billing, Clare B.
    Watsky, Eric J.
    Gong, Jason
    Williams, Kathryn E.
    Reeves, Karen R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01): : 47 - 55
  • [5] Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: Effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice
    Holladay, MW
    Bai, H
    Li, YH
    Lin, NH
    Daanen, JF
    Ryther, KB
    Wasicak, JT
    Kincaid, JF
    He, Y
    Hettinger, AM
    Huang, P
    Anderson, DJ
    Bannon, AW
    Buckley, MJ
    Campbell, JE
    Donnelly-Roberts, DL
    Gunther, KL
    Kim, DJB
    Kuntzweiler, TA
    Sullivan, JP
    Decker, MW
    Arneric, SP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (19) : 2797 - 2802
  • [6] Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors
    Holladay, MW
    Wasicak, JT
    Lin, NH
    He, Y
    Ryther, KB
    Bannon, AW
    Buckley, MJ
    Kim, DJB
    Decker, MW
    Anderson, DJ
    Campbell, JE
    Kuntzweiler, TA
    Donnelly-Roberts, DL
    Piattoni-Kaplan, M
    Briggs, CA
    Williams, M
    Arneric, SP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (04) : 407 - 412
  • [7] Epibatidine analogues as selective ligands for the αxβ2-containing subtypes of nicotinic acetylcholine receptors
    Huang, YY
    Zhu, ZH
    Xiao, YX
    Laruelle, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (19) : 4385 - 4388
  • [8] Nicotinic acetylcholine receptors: From basic science to therapeutics
    Hurst, Raymond
    Rollema, Hans
    Bertrand, Daniel
    [J]. PHARMACOLOGY & THERAPEUTICS, 2013, 137 (01) : 22 - 54
  • [9] Neuronal nicotinic acetylcholine receptors: Structural revelations, target identifications, and therapeutic inspirations
    Jensen, AA
    Frolund, B
    Lijefors, T
    Krogsgaard-Larsen, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) : 4705 - 4745
  • [10] Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats
    Johnson, Joshua E.
    Slade, Susan
    Wells, Corinne
    Petro, Ann
    Sexton, Hannah
    Rezvani, Amir H.
    Brown, Milton L.
    Paige, Mikell A.
    McDowell, Brian E.
    Xiao, Yingxian
    Kellar, Kenneth J.
    Levin, Edward D.
    [J]. PSYCHOPHARMACOLOGY, 2012, 222 (02) : 269 - 276